1
|
Deng W, Fu M, Huang J. Mechanism of pruritus ani lotion combined with Huajiao-Gancao-Bingpian oil for pruritus ani treatment based on network pharmacology and molecular dynamics. Postepy Dermatol Alergol 2024; 41:203-214. [PMID: 38784930 PMCID: PMC11110214 DOI: 10.5114/ada.2023.135761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 10/10/2023] [Indexed: 05/25/2024] Open
Abstract
Introduction Pruritus ani lotion combined with a Chinese medicine formula named Huajiao (Pericarpium Zanthoxyli Bungeani)-Gancao (Radix Glycyrrhizae)-Bingpian (Borneol) is effective in treating pruritus ani. Aim To investigate the mechanism of traditional Chinese medicine (TCM) in pruritus ani via network pharmacology and molecular dynamics (MD). Material and methods The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was utilised to screen active ingredients and their corresponding targets. Genes associated with pruritus ani were collected through GeneCards. Protein-protein interaction (PPI) network between target genes of the active ingredients of this formula and genes associated with pruritus ani was established through the STRING database. A drug-active ingredient-gene interaction network was constructed using Cytoscape with the top 50 genes in affinity coefficients. Molecular docking and MD simulation analysis were performed. Results Epidermal growth factor receptor (EGFR) and Signal Transducer and Activator of Transcription 3 (STAT3) were core genes. Direct targeting of EGFR by the active ingredients (quercetin and luteolin) and direct targeting of STAT3 by the active ingredient (licochalcone A) may be key molecular mechanisms for the treatment of pruritus ani. Simulated trajectories of structural nuclear motion by MD also revealed that the binding of two pairs of molecules was relatively stable. Conclusions This study unravels potential targets, active ingredients, and mechanisms of pruritus ani lotion combined with Huajiao-Gancao-Bingpian oil in the treatment of pruritus ani, providing a reference for future treatment.
Collapse
Affiliation(s)
- Wenkuo Deng
- Anorectal Department, Xiangyang Hospital of Traditional Chinese Medicine [Xiangyang Institute of Traditional Chinese Medicine], Xiangyang City, Hubei Province, China
| | - Minghong Fu
- Anorectal Department, Xiangyang Hospital of Traditional Chinese Medicine [Xiangyang Institute of Traditional Chinese Medicine], Xiangyang City, Hubei Province, China
| | - Jintao Huang
- Anorectal Department, Xiangyang Hospital of Traditional Chinese Medicine [Xiangyang Institute of Traditional Chinese Medicine], Xiangyang City, Hubei Province, China
| |
Collapse
|
2
|
Zhang Y, Wang Y, Yan K, Li H, Zhang X, Essola JM, Ding C, Chang K, Qing G, Zhang F, Tan Y, Peng T, Wang X, Jiang M, Liang X, Hua Q. Traditional Chinese Medicine Formulae QY305 Reducing Cutaneous Adverse Reaction and Diarrhea by its Nanostructure. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2024; 11:e2306140. [PMID: 38044276 PMCID: PMC10837375 DOI: 10.1002/advs.202306140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 11/08/2023] [Indexed: 12/05/2023]
Abstract
Traditional Chinese medicine (TCM) is widely used in clinical practice, including skin and gastrointestinal diseases. Here, a potential TCM QY305 (T-QY305) is reported that can modulate the recruitment of neutrophil in skin and colon tissue thus reducing cutaneous adverse reaction and diarrhea induced by epidermal growth factor receptor inhibitors (EGFRIs). On another hand, the T-QY305 formula, through regulating neutrophil recruitment features would highlight the presence of N-QY305, a subunit nanostructure contained in T-QY305, and confirm its role as potentially being the biomaterial conferring to T-QY305 its pharmacodynamic features. Here, the clinical records of two patients are analyzed expressing cutaneous adverse reaction and demonstrate positive effect of T-QY305 on the simultaneous inhibition of both cutaneous adverse reaction and diarrhea in animal models. The satisfying results obtained from T-QY305, lead to further process to the isolation of N-QY305 from T-QY305, in order to demonstrate that the potency of T-QY305 originates from the nanostructure N-QY305. Compared to T-QY305, N-QY305 exhibits higher potency upon reducing adverse reactions. The data represent a promising candidate for reducing cutaneous adverse reaction and diarrhea, meanwhile proposing a new strategy to highlight the presence of nanostructures being the "King" of Chinese medicine formula as the pharmacodynamic basis.
Collapse
Affiliation(s)
- Ya‐Li Zhang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
- CAS Center for Excellence in NanoscienceCAS Key Laboratory for Biomedical Effects of Nanomaterials and NanosafetyChinese Academy of Sciences and National Center for Nanoscience and Technology of ChinaBeijing100190China
| | - Ya‐Lei Wang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Ke Yan
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Haiyan Li
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Xinyu Zhang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Julien Milon Essola
- CAS Center for Excellence in NanoscienceCAS Key Laboratory for Biomedical Effects of Nanomaterials and NanosafetyChinese Academy of Sciences and National Center for Nanoscience and Technology of ChinaBeijing100190China
| | - Chengcheng Ding
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Kexin Chang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Guangchao Qing
- CAS Center for Excellence in NanoscienceCAS Key Laboratory for Biomedical Effects of Nanomaterials and NanosafetyChinese Academy of Sciences and National Center for Nanoscience and Technology of ChinaBeijing100190China
| | - Fuxue Zhang
- CAS Center for Excellence in NanoscienceCAS Key Laboratory for Biomedical Effects of Nanomaterials and NanosafetyChinese Academy of Sciences and National Center for Nanoscience and Technology of ChinaBeijing100190China
| | - Yan Tan
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Tiantian Peng
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Xu Wang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Miao Jiang
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| | - Xing‐Jie Liang
- CAS Center for Excellence in NanoscienceCAS Key Laboratory for Biomedical Effects of Nanomaterials and NanosafetyChinese Academy of Sciences and National Center for Nanoscience and Technology of ChinaBeijing100190China
| | - Qian Hua
- School of Life SciencesSchool of Traditional Chinese MedicineBeijing University of Chinese MedicineBeijing102488China
| |
Collapse
|
3
|
Wang Y, Cheng S, Zhang H, Zhang Y, Ding C, Peng T, Chen W, Yang K, Zhang J, Tan Y, Wang X, Liu Z, Wei P, Jiang M, Hua Q. Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model. Recent Pat Anticancer Drug Discov 2024; 19:308-315. [PMID: 37723963 DOI: 10.2174/1574892818666230727143750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2022] [Revised: 03/26/2023] [Accepted: 05/03/2023] [Indexed: 09/20/2023]
Abstract
BACKGROUND Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), frequently causes side effects when used to treat non-small cell lung cancer. OBJECTIVE The purpose of this experiment was to investigate the side effect of gefitinib on the skin and colon of mice. METHODS Male Balb/c nu-nu nude mice aged 4-5 weeks were used as xenograft tumor models, and gefitinib at 150 mg/kg and 225 mg/kg was started at 9 days after the xenograft tumor grew out. The mice's weights and tumor volumes were tracked concurrently, and the mouse skin adverse reactions and diarrhea were observed during the treatment. The animal tissues were subjected to biochemical and pathological evaluations after 14 days. RESULTS Gefitinib effectively decreased the size and weight of transplanted tumors in nude mice, while also lowering body weight and raising indexes of the liver and spleen. Gefitinib could cause skin adverse reactions and diarrhea in mice. Further pathological investigation revealed tight junction- related markers in the mice's skin and colon to be reduced and macrophages and neutrophils to be increased after gefitinib treatment. CONCLUSION The findings imply that gefitinib has negative effects on the skin and colon. Gefitinib- induced skin and colon adverse reactions in mice have been successfully modeled in this study.
Collapse
Affiliation(s)
- Yalei Wang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Shuo Cheng
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Huawei Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Yali Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Chengcheng Ding
- School of Life Sciences, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Tiantian Peng
- School of Acupuncture and Massage, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Weihang Chen
- School of Acupuncture and Massage, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Ke Yang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Jiani Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Yan Tan
- School of Life Sciences, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Xu Wang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Zhaoheng Liu
- School of Life Sciences, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Peng Wei
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Miao Jiang
- School of Life Sciences, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| | - Qian Hua
- School of Life Sciences, Beijing University of Chinese Medicine, No. 11 North 3rd Ring, Eastern Road, Beijing, 100029, China
| |
Collapse
|
4
|
Zhu C, Zhang Z, Wang S, Sun Z. Study on the mechanism of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen in sedation and tranquillising mind. Mol Divers 2023:10.1007/s11030-023-10756-x. [PMID: 37917323 DOI: 10.1007/s11030-023-10756-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Accepted: 10/22/2023] [Indexed: 11/04/2023]
Abstract
This study analysed the pharmacological mechanism of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen in sedation and tranquillising mind using network pharmacology methods. The findings of this study aimed to serve as a reference for the development of novel drugs and the clinical expansion and application of traditional Chinese medicine formulas. The chemical constituents and therapeutic targets of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen were acquired from TCMSP, HERB, and ETCM databases. Active components were identified using ADME criteria, while the primary targets associated with sedation and mental tranquillity were obtained from GENECARDS, OMIM, and DRUGBANK databases. A protein-protein interaction (PPI) network analysis was conducted using the STRING platform to investigate potential functional protein modules by the network. The METASCAPE platform was employed for the study of the "component-target" and its associated biological processes and pathways. Subsequently, the "component-target" network was constructed using Cytoscape 3.9.1 software. Finally, the validation of molecular docking was conducted through AUTODOCK. The findings revealed that Quercetin, Atropine, Dauricine, (S)-Coclaurine, and other active ingredients were identified as the core constituents of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen. Additionally, PTGS2, PTGS1, MAOB, GABRA1, SLC6A2, ADRB2, CHRM1, HTR2A, and other targets were identified as the core targets. The results of the molecular docking analysis demonstrated that Quercetin, Atropine, Dauricine, and (S)-Coclaurine exhibited binding solid affinity towards PTGS2 and PTGS1. The predominant biological pathways associated with sedation and tranquilisation primarily involved Neuroactive ligand-receptor interaction and activation of receptors involved in chemical carcinogenesis. This study provided initial findings on the multi-component, multi-target, and multi-pathway mechanism underlying the sedative and tranquillising effects of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen. These findings had the potential to serve as a foundation for the future development and utilisation of Gastrodiae Rhizoma, Lycii Fructus, and Ziziphi Spinosae Semen.
Collapse
Affiliation(s)
- Chenghao Zhu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Zhengru Zhang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Shangtao Wang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Zhirong Sun
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
| |
Collapse
|
5
|
Zhang YL, Wang YL, Yan K, Deng QQ, Li FZ, Liang XJ, Hua Q. Nanostructures in Chinese herbal medicines (CHMs) for potential therapy. NANOSCALE HORIZONS 2023; 8:976-990. [PMID: 37278697 DOI: 10.1039/d3nh00120b] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
With its long clinical history, traditional Chinese medicine (TCM) has gained acceptance for its specific efficacy and safety in the treatment of multiple diseases. Nano-sized materials study of Chinese herbal medicines (CHMs) leads to an increased understanding of assessing TCM therapies, which may be a promising way to illustrate the material basis of CHMs through their processing and extraction. In this review, we provide an overview of the nanostructures of natural and engineered CHMs, including extracted CHMs, polymer nanoparticles, liposomes, micelles, and nanofibers. Subsequently, the applications of these CHM-derived nanostructures to particular diseases are summarized and discussed. Additionally, we discuss the advantages of these nanostructures for studying the therapeutic efficacy of CHMs. Finally, the key challenges and opportunities for the development of these nanostructures are outlined.
Collapse
Affiliation(s)
- Ya-Li Zhang
- Beijing University of Chinese Medicine, Beijing, China.
- Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
| | - Ya-Lei Wang
- Beijing University of Chinese Medicine, Beijing, China.
| | - Ke Yan
- Beijing University of Chinese Medicine, Beijing, China.
| | - Qi-Qi Deng
- Beijing University of Chinese Medicine, Beijing, China.
| | - Fang-Zhou Li
- Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
| | - Xing-Jie Liang
- Laboratory of Controllable Nanopharmaceuticals, Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
| | - Qian Hua
- Beijing University of Chinese Medicine, Beijing, China.
| |
Collapse
|